Table 1 Characteristics of U.S. Adults with COPD, NHANES 2007–2012
From: Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD
Demographics | Â |
|---|---|
Age (years) | 60.6 ± 8.4 |
Male (%) | 63.5 |
Ethnicity (%) | |
Non-hispanic White | 85.1 |
Others | 14.8 |
Pack-Years | 30.4 ± 23.8 |
BMI, kg/m2 | 27.3 ± 4.9 |
Dietary Intake | |
Energy (kcal) | 2112 ± 680 |
Omega-3 | |
EPA + DHA (g) | 0.11 ± 0.21 |
ALA (g) | 1.71 ± 0.89 |
Omega-6 | |
LA (g) | 16.5 ± 8.0 |
Lung Function | Â |
FEV1, L | 2.5 ± 0.7 |
FVC, L | 3.9 ± 0.9 |
FEV1/FVC | 0.63 ± 0.06 |
Symptom Prevalence (%) | |
Chronic cough | 19.2 |
Nocturnal cough | 6.9 |
Phlegm | 17.7 |
Wheeze (any) | 21.0 |
Nocturnal Wheeze | 9.4 |
Wheeze with exertion | 8.1 |
Meds for wheeze | 5.4 |